Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Pacific Biosciences of California, Inc.

Market Cap 419M 361M 333M 312M 587M 39.64B 593M 3.93B 1.53B 19.41B 1.57B 1.54B 67.28B P/E Ratio 2026 *
-3.29x
P/E Ratio 2027 * -2.88x
Enterprise Value 419M 361M 333M 312M 587M 39.64B 593M 3.93B 1.53B 19.41B 1.57B 1.54B 67.28B EV / Sales 2026 *
2.5x
EV / Sales 2027 * 2.16x
Free-Float
91.23%
Yield 2026 *
-
Yield 2027 * -
1 day+2.27%
1 week-1.46%
Current month-9.40%
1 month+20.54%
3 months-0.74%
6 months-33.17%
Current year-27.81%
1 week 1.3
Extreme 1.3
1.4
1 month 1.09
Extreme 1.09
1.77
Current year 1.09
Extreme 1.09
2.73
1 year 1.09
Extreme 1.09
2.73
3 years 0.85
Extreme 0.8511
14.55
5 years 0.85
Extreme 0.8511
36.36
10 years 0.85
Extreme 0.8511
53.69
Manager TitleAgeSince
Chief Executive Officer 58 2020-09-13
Director of Finance/CFO 57 2025-03-30
Chief Operating Officer 53 2021-01-07
Director TitleAgeSince
Director/Board Member 67 2003-12-31
Director/Board Member 72 2008-12-31
Director/Board Member 69 2012-01-17
Date Insider Type Main position Quantity % Market Cap.
06-02Free

Director

223,492 0.0720%
06-02Free

Director

74,497 0.0240%
06-02Free

Director

223,492 0.0720%
Change 5-day change 1-year change 3-year change Capi.($)
+2.27%-1.46%-2.17%-89.41% 419M
-0.23%-4.34%+16.68%-12.04% 176B
+0.12%-2.24%-19.65%+26.63% 148B
+0.14%-3.75%-9.83%-25.00% 128B
+0.34%-4.17%-53.77%-13.62% 69.74B
+2.67%+1.19%+18.39%-3.65% 51B
+0.97%+0.60%-23.33%-33.14% 45.7B
-1.72%-5.27%+7.83%+5.95% 36.25B
+0.78%-2.86%+3.66%+33.93% 35.4B
-2.36%-4.21%-13.22%-19.61% 28.76B
Average +0.17%-2.57%-7.54%-13.00% 71.9B
Weighted average by Cap. +0.06%-2.86%-7.07%-4.49%

Financials

2026 *2027 *
Net sales 168M 145M 133M 125M 235M 15.87B 237M 1.57B 613M 7.77B 630M 616M 26.93B 194M 167M 154M 144M 271M 18.33B 274M 1.82B 708M 8.97B 727M 712M 31.1B
Net income -129M -111M -102M -95.8M -180M -12.16B -182M -1.21B -470M -5.95B -483M -472M -20.63B -149M -128M -118M -111M -208M -14.05B -210M -1.39B -543M -6.88B -558M -546M -23.85B
Net Debt - -
Logo Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops, and manufactures sequencing solutions. Its products and technology include HiFi long-read sequencing technology, which addresses a set of applications including human germline sequencing, plant and animal sciences, infectious disease, microbiology, oncology, and other applications. Its sequencing technology supports oncology research by enabling analysis of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), providing researchers with insight into cancer biology. It focuses on creating sequencing systems to provide customers with a view of genomes, transcriptomes, and epigenomes. Its customers include academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations (CROs), pharmaceutical companies, and agricultural companies.
Employees
485
Date Price Change Volume
26-06-16 1.350 $ +2.27% 3,742,765
26-06-15 1.320 $ +0.76% 5,298,162
26-06-12 1.310 $ -2.96% 4,981,024
26-06-11 1.350 $ -1.46% 5,069,275
26-06-10 1.370 $ 0.00% 5,224,296
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
1.350USD
Average target price
2.458USD
Spread / Average Target
+82.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PACB Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!